These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. N-benzoxazol-2-yl-N'-1-(isoquinolin-3-yl-ethylidene)-hydrazine, a novel compound with antitumor activity, induces radicals and dissipation of mitochondrial membrane potential. Hofmann J; Easmon J; Puerstinger G; Heinisch G; Jenny M; Shtil AA; Hermann M; Condorelli DF; Sciré S; Musumarra G Invest New Drugs; 2009 Jun; 27(3):189-202. PubMed ID: 18612590 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, cytotoxicity, and antitumor activity of copper(II) and iron(II) complexes of (4)N-azabicyclo[3.2.2]nonane thiosemicarbazones derived from acyl diazines. Easmon J; Pürstinger G; Heinisch G; Roth T; Fiebig HH; Holzer W; Jäger W; Jenny M; Hofmann J J Med Chem; 2001 Jun; 44(13):2164-71. PubMed ID: 11405653 [TBL] [Abstract][Full Text] [Related]
5. Investigations on the mechanism of action of the novel antitumor agents 2-benzothiazolyl, 2-benzoxazolyl, and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine. Hall IH; Peaty NJ; Henry JR; Easmon J; Heinisch G; Pürstinger G Arch Pharm (Weinheim); 1999 Apr; 332(4):115-23. PubMed ID: 10327884 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure-activity relationships, and antitumor studies of 2-benzoxazolyl hydrazones derived from alpha-(N)-acyl heteroaromatics. Easmon J; Pürstinger G; Thies KS; Heinisch G; Hofmann J J Med Chem; 2006 Oct; 49(21):6343-50. PubMed ID: 17034140 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis. Nandy P; Lien EJ; Avramis VI Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093 [TBL] [Abstract][Full Text] [Related]
8. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related]
9. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; De Placido S; Bianco AR; Tortora G Clin Cancer Res; 2000 May; 6(5):2053-63. PubMed ID: 10815932 [TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of miconazole on human colon carcinoma xenografts in nude mice through induction of apoptosis and G0/G1 cell cycle arrest. Wu CH; Jeng JH; Wang YJ; Tseng CJ; Liang YC; Chen CH; Lee HM; Lin JK; Lin CH; Lin SY; Li CP; Ho YS Toxicol Appl Pharmacol; 2002 Apr; 180(1):22-35. PubMed ID: 11922774 [TBL] [Abstract][Full Text] [Related]
11. N-(1'-naphthyl)-3,4,5-trimethoxybenzohydrazide as microtubule destabilizer: Synthesis, cytotoxicity, inhibition of cell migration and in vivo activity against acute lymphoblastic leukemia. Salum LB; Mascarello A; Canevarolo RR; Altei WF; Laranjeira AB; Neuenfeldt PD; Stumpf TR; Chiaradia-Delatorre LD; Vollmer LL; Daghestani HN; de Souza Melo CP; Silveira AB; Leal PC; Frederico MJ; do Nascimento LF; Santos AR; Andricopulo AD; Day BW; Yunes RA; Vogt A; Yunes JA; Nunes RJ Eur J Med Chem; 2015; 96():504-18. PubMed ID: 25951294 [TBL] [Abstract][Full Text] [Related]
12. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo. Zhao YY; Tian Y; Zhang J; Xu F; Yang YP; Huang Y; Zhao HY; Zhang JW; Xue C; Lam MH; Yan L; Hu ZH; Dinglin XX; Zhang L Drug Des Devel Ther; 2014; 8():1827-37. PubMed ID: 25336925 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476 [TBL] [Abstract][Full Text] [Related]
14. Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer. Tu S; Wai-Yin Sun R; Lin MC; Tao Cui J; Zou B; Gu Q; Kung HF; Che CM; Wong BC Cancer; 2009 Oct; 115(19):4459-69. PubMed ID: 19572413 [TBL] [Abstract][Full Text] [Related]
15. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents. Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635 [TBL] [Abstract][Full Text] [Related]
16. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo. Kuo CC; Hsieh HP; Pan WY; Chen CP; Liou JP; Lee SJ; Chang YL; Chen LT; Chen CT; Chang JY Cancer Res; 2004 Jul; 64(13):4621-8. PubMed ID: 15231674 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL. Woo JK; Kang JH; Jang YS; Ro S; Cho JM; Kim HM; Lee SJ; Oh SH Oncol Rep; 2015 Apr; 33(4):1947-55. PubMed ID: 25672292 [TBL] [Abstract][Full Text] [Related]
18. The novel indole compound SK228 induces apoptosis and FAK/Paxillin disruption in tumor cell lines and inhibits growth of tumor graft in the nude mouse. Huang SM; Hsu PC; Chen MY; Li WS; More SV; Lu KT; Wang YC Int J Cancer; 2012 Aug; 131(3):722-32. PubMed ID: 22015944 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide. Burres NS; Clement JJ Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652 [TBL] [Abstract][Full Text] [Related]